Glycopeptide Biomarkers in Serum Haptoglobin for Hepatocellular Carcinoma Detection in Patients with Nonalcoholic Steatohepatitis
Jianhui Zhu(Qingdao University), David M. Lubman(University of Michigan), Gabriela Grigorean(University of California, Davis), Neehar D. Parikh(University of Michigan), Jie Zhang(University of Michigan), Junfeng Huang(Central China Normal University), Lingjun Li(University of Wisconsin–Madison), Zhengwei Chen(University of Wisconsin–Madison), Amit G. Singal(Southwestern Medical Center), Yu Lin(University of Michigan–Ann Arbor), Suyu Liu(The University of Texas MD Anderson Cancer Center)
Cited by 53
Related Papers
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
|Hepatology|2023|1.6k
O-GlcNAc modification blocks the aggregation and toxicity of the protein α-synuclein associated with Parkinson's disease
|Nature Chemistry|2015|305
Detection of Hepatocellular Carcinoma at Advanced Stages Among Patients in the HALT-C Trial: Where Did Surveillance Fail?
|The American Journal of Gastroenterology|2013|227
Racial, Social, and Clinical Determinants of Hepatocellular Carcinoma Surveillance
|The American Journal of Medicine|2014|177